Evidence map›Paper›PMID 42179261›Full record

ReviewJournal of the American Heart Association2026

Value-Based Medicine in the Management of Abdominal Aortic Aneurysms.

Daniel Raskin, Sasan Partovi, Francis Caputo, Sean P Lyden, Enrico Prajiante Bertolino, Gregory Piazza, Matthew J Eagleton, Lee Kirksey

Abstract readReview
In one paragraph

Review in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniel RaskinInterventional Radiology Division Cleveland Clinic Cleveland OH USA.ORCID 0000-0003-3584-3748
Sasan PartoviInterventional Radiology Division Cleveland Clinic Cleveland OH USA.
Francis CaputoInterventional Radiology Division Cleveland Clinic Cleveland OH USA.
Sean P LydenVascular Surgery, Heart, Vascular and Thoracic Institute Cleveland Clinic Cleveland OH USA.ORCID 0000-0003-1666-017X
Enrico Prajiante BertolinoVascular Surgery, Heart, Vascular and Thoracic Institute Cleveland Clinic Cleveland OH USA.ORCID 0009-0003-1254-0565
Gregory PiazzaDivision of Cardiovascular Medicine, Department of Medicine Brigham and Women's Hospital, Harvard Medical School Boston MA USA.ORCID 0000-0002-1722-2983
Matthew J EagletonDivision of Vascular and Endovascular Surgery, Department of Surgery Massachusetts General Hospital Boston MA USA.ORCID 0000-0002-1949-6283
Lee KirkseyVascular Surgery, Heart, Vascular and Thoracic Institute Cleveland Clinic Cleveland OH USA.ORCID 0000-0001-5189-1999

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The implementation of value-based medicine reflects a transformation from volume incentivized care to a quality-of-care directed reimbursement model. Value-based medicine aims to concurrently improve health care quality and control growing health care expenditures by aligning evidence-based and patient-centered interventions with sustainable resource use. We apply a value-based medicine framework to abdominal aortic aneurysm care delivery, highlighting opportunities to improve patient outcomes, optimize resource allocation, and reduce health care expenditures across the continuum of disease management. A comprehensive literature review was conducted, evaluating recent clinical guidelines, economic analyses, and real-world practice data on abdominal aortic aneurysm management, including screening, surveillance, timing of intervention, modality selection (endovascular aneurysm repair versus open surgical repair), and follow-up strategies. Contemporary real-world published practice patterns reveal wide variation in screening uptake, surveillance intensity, repair criteria thresholds, procedure and device selection, and post-endovascular aneurysm repair imaging, producing inconsistent outcomes and inefficient spending. Endovascular aneurysm repair predominates in elective abdominal aortic aneurysm repair because of lower perioperative morbidity and shorter length of stay; however, downstream costs from surveillance, endoleak management, and reinterventions may erode its initial economic advantage over open surgical repair. Key value drivers include risk-aligned screening, standardized surveillance anchored to anatomy and device risk, judicious use of advanced imaging, optimized perioperative pathways, and careful device selection. Savings opportunities include predictive analytics to individualize surveillance, deescalation of routine computed tomography after documented sac shrinkage, smoking cessation, medical optimization, and structured shared decision-making aligned with life expectancy and patient preferences. Integrating value-based medicine principles into abdominal aortic aneurysm care through regional centers of excellence, bundled reimbursement models, transparent cost structures, and surveillance strategies may offer a pragmatic roadmap to achieve safer, economically sustainable, and patient-centered management, ultimately advancing both clinical outcomes and cost efficiency.

Indexed as

Aortic Aneurysm, AbdominalEndovascular Aneurysm RepairValue-Based Health CareCost-Benefit AnalysisHealth Care CostsHumansTreatment Outcomeabdominal aortic aneurysmhealth care costspatient outcomesvalue‐based medicinevascular surgery

Identifiers

PMID42179261
PMCPMC13315340

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.